Distinguished in Asthma

Dr. Karen S. Mccoy

Pediatric Pulmonology | Pediatrics | Pulmonary Medicine
Pediatric Academic Association, Inc.
700 Children's Dr, 
Columbus, OH 
Accepting New Patients
Distinguished in Asthma
Pediatric Academic Association, Inc.
700 Children's Dr, 
Columbus, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Karen Mccoy is a Pediatric Pulmonologist and a Pediatrics provider in Columbus, Ohio. Dr. Mccoy is rated as a Distinguished provider by MediFind in the treatment of Asthma. Her top areas of expertise are Cystic Fibrosis, Asthma, Exocrine Pancreatic Insufficiency, Gastroesophageal Reflux Disease (GERD), and Lung Transplant. Dr. Mccoy is currently accepting new patients.

Her clinical research consists of co-authoring 85 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 20 articles in the study of Asthma.

Specialties
Pediatric Pulmonology
Pediatrics
Pulmonary Medicine
Licenses
Pediatrics in OH
Hospital Affiliations
Nationwide Children's Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Ohio Health Group
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

PEDIATRIC ACADEMIC ASSOCIATION, INC.
700 Children's Dr, Columbus, OH 43205

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Multi-Center Study of Non-Invasive Colorectal Cancer Evaluation in Cystic Fibrosis (NICE-CF)
A Multi-Center Study of Non-Invasive Colorectal Cancer Evaluation in Cystic Fibrosis (NICE-CF)
Enrollment Status: Active_not_recruiting
Publish Date: May 04, 2025
Intervention Type: Procedure
Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis
Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis
Enrollment Status: Enrolling_by_invitation
Publish Date: April 02, 2024
Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis
Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis
Enrollment Status: Enrolling_by_invitation
Publish Date: April 02, 2024
A Phase 1b/2a, Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of AP-PA02 Multi-Phage Therapeutic Candidate for Inhalation in Subjects With Cystic Fibrosis and Chronic Pulmonary Pseudomonas Aeruginosa (Pa) Infection
A Phase 1b/2a, Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of AP-PA02 Multi-Phage Therapeutic Candidate for Inhalation in Subjects With Cystic Fibrosis and Chronic Pulmonary Pseudomonas Aeruginosa (Pa) Infection
Enrollment Status: Completed
Publish Date: January 31, 2024
Intervention Type: Other, Biological
Study Drug: AP-PA02 Bacteriophage
Study Phase: Phase 1/Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis
Enrollment Status: Completed
Publish Date: January 18, 2023
Intervention Type: Drug, Other
Study Drug: Lenabasum
Study Phase: Phase 2
A Phase III, Randomized, Double-blind, Placebo-controlled Study of AeroVanc for the Treatment of Persistent Methicillin-resistant Staphylococcus Aureus Lung Infection in Cystic Fibrosis Patients
A Phase III, Randomized, Double-blind, Placebo-controlled Study of AeroVanc for the Treatment of Persistent Methicillin-resistant Staphylococcus Aureus Lung Infection in Cystic Fibrosis Patients
Enrollment Status: Completed
Publish Date: December 16, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2 Open Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dose Levels of Subcutaneously Administered ELX-02 in Patients With Cystic Fibrosis With at Least One G542X Allele
A Phase 2 Open Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dose Levels of Subcutaneously Administered ELX-02 in Patients With Cystic Fibrosis With at Least One G542X Allele
Enrollment Status: Completed
Publish Date: November 22, 2022
Intervention Type: Drug
Study Drug: ELX-02 Ribosomal-Selective Glycoside
Study Phase: Phase 2
Phase 1b, Randomized, Double-blind, Placebo-controlled, Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of QR-010 in Subjects With Homozygous ΔF508 Cystic Fibrosis
Phase 1b, Randomized, Double-blind, Placebo-controlled, Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of QR-010 in Subjects With Homozygous ΔF508 Cystic Fibrosis
Enrollment Status: Completed
Publish Date: February 06, 2019
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 7 Less Clinical Trials

85 Total Publications

CFTR mutation leads to intrinsic dysfunction in neutrophils from people with Cystic Fibrosis.
CFTR mutation leads to intrinsic dysfunction in neutrophils from people with Cystic Fibrosis.
Journal: bioRxiv : the preprint server for biology
Published: June 12, 2025
Similar Doctors
Distinguished in Asthma
Dr. Shahid I. Sheikh
Pediatric Pulmonology | Pediatrics | Pediatric Allergy and Immunology
Distinguished in Asthma
Dr. Shahid I. Sheikh
Pediatric Pulmonology | Pediatrics | Pediatric Allergy and Immunology

Pediatric Academic Association, Inc.

700 Children's Dr, 
Columbus, OH 
 (0.1 miles away)
614-722-4579
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Shahid Sheikh is a Pediatric Pulmonologist and a Pediatrics provider in Columbus, Ohio. Dr. Sheikh is rated as an Advanced provider by MediFind in the treatment of Asthma. His top areas of expertise are Cystic Fibrosis, Asthma, Bronchopulmonary Dysplasia, Short Rib-Polydactyly Syndrome Type 1, and Lung Transplant. Dr. Sheikh is currently accepting new patients.

Distinguished in Asthma
Dr. Jarrod T. Bruce
Pulmonary Medicine | Intensive Care Medicine
Distinguished in Asthma
Dr. Jarrod T. Bruce
Pulmonary Medicine | Intensive Care Medicine

Fairfield Healthcare Professionals Inc

401 N Ewing St, 
Lancaster, OH 
 (26.8 miles away)
740-689-6600
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jarrod Bruce is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Lancaster, Ohio. Dr. Bruce is rated as a Distinguished provider by MediFind in the treatment of Asthma. His top areas of expertise are Asthma, Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Small Cell Lung Cancer (SCLC), and Gastrostomy. Dr. Bruce is currently accepting new patients.

Distinguished in Asthma
Dr. Haval M. Saadlla
Pulmonary Medicine | Intensive Care Medicine
Distinguished in Asthma
Dr. Haval M. Saadlla
Pulmonary Medicine | Intensive Care Medicine

Mount Carmel Healthproviders Two LLC

5300 N Meadows Dr, 
Grove City, OH 
 (8.6 miles away)
614-663-3877
Languages Spoken:
English, Arabic, Arabic - Jordanian, Kurdish
See accepted insurances
Accepting New Patients

Haval Saadlla is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Grove City, Ohio. Dr. Saadlla is rated as a Distinguished provider by MediFind in the treatment of Asthma. His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Obstructive Sleep Apnea, Lung Nodules, and Advanced Bronchoscopy. Dr. Saadlla is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mccoy's expertise for a condition
ConditionClose
View All 8 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile